BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16284691)

  • 1. Comparative assessment of the cytotoxic effects of carboxylato-bridged dinuclear platinum (II) complexes against human tumor cell lines.
    Momekov G; Bakalova A; Konstantinov S; Todorov D; Karaivanova M
    Neoplasma; 2005; 52(6):469-75. PubMed ID: 16284691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
    Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM
    Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro toxicological evaluation of a dinuclear platinum(II) complex with acetate ligands.
    Momekov G; Ferdinandov D; Bakalova A; Zaharieva M; Konstantinov S; Karaivanova M
    Arch Toxicol; 2006 Sep; 80(9):555-60. PubMed ID: 16485120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells.
    Bielawska A; Popławska B; Surazyński A; Czarnomysy R; Bielawski K
    Eur J Pharmacol; 2010 Sep; 643(1):34-41. PubMed ID: 20598681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
    Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs.
    Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J
    J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Rinke K; Grünert R; Bednarski PJ
    Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
    Matesanz AI; Joie C; Souza P
    Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
    Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
    J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic and proapoptotic effects of new Pd(II) and Pt(II)-complexes with 3-ethanimidoyl-2-methoxy-2H-1,2-benzoxaphosphinin-4-ol-2-oxide.
    Budzisz E; Krajewska U; Rózalski M
    Pol J Pharmacol; 2004; 56(4):473-8. PubMed ID: 15520503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, physicochemical and in vitro pharmacological investigation of new platinum (II) complexes with some cycloalkanespiro-5'-hydantoins.
    Bakalova A; Buyukliev R; Momekov G; Ivanov D; Todorov D; Konstantinov S; Karaivanova M
    Eur J Med Chem; 2005 Jun; 40(6):590-6. PubMed ID: 15922842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
    Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
    J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents.
    Keter FK; Kanyanda S; Lyantagaye SS; Darkwa J; Rees DJ; Meyer M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):127-38. PubMed ID: 18350297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.
    Ravera M; Gabano E; Zanellato I; Bonarrigo I; Escribano E; Moreno V; Font-Bardia M; Calvet T; Osella D
    Dalton Trans; 2012 Mar; 41(11):3313-20. PubMed ID: 22286213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.